Myeloma Therapy for Monoclonal Gammopathy of Thrombotic Significance

N Engl J Med. 2024 Aug 8;391(6):570-571. doi: 10.1056/NEJMc2406453.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Bortezomib / therapeutic use
  • Dexamethasone / therapeutic use
  • Female
  • Fondaparinux / therapeutic use
  • Humans
  • Male
  • Mesenteric Ischemia / blood
  • Mesenteric Ischemia / diagnosis
  • Mesenteric Ischemia / etiology
  • Mesenteric Ischemia / surgery
  • Middle Aged
  • Paraproteinemias* / blood
  • Paraproteinemias* / complications
  • Paraproteinemias* / diagnosis
  • Paraproteinemias* / drug therapy
  • Thrombocytopenia* / blood
  • Thrombocytopenia* / diagnosis
  • Thrombocytopenia* / therapy
  • Treatment Outcome
  • Venous Thrombosis* / blood
  • Venous Thrombosis* / diagnosis
  • Venous Thrombosis* / etiology
  • Venous Thrombosis* / surgery

Substances

  • Fondaparinux
  • daratumumab
  • Bortezomib
  • Dexamethasone
  • Antibodies, Monoclonal